Table 1.
Clinical characteristics of the preterm population.
|
Total population (28+0-36+6 weeks) n = 148 |
Early preterm (28+0-33+6 weeks) n = 86 |
Late preterm (34+0-36+6 weeks) n = 62 |
Difference between early and late preterm (p-value) |
|
|---|---|---|---|---|
| Sex |
M 85 (57.4%) F 63 (43.6%) |
M 46 (53.5%) F 40 (46.5%) |
M 39 (62.9%) F 23 (42.6%) |
M 0.255 F 0.639 |
| Birthweight | 1,944.5 ± 565.7 g | 1,670.4 ± 439 g | 2,319.1 ± 502.9 g | < 0.001 |
| 1-min Apgar score | 7.5 ± 1.6 | 7.0 ± 1.7 | 8.1 ± 1.4 | < 0.001 |
| 5-min Apgar score | 8.7 ± 1.0 | 8.4 ± 1.0 | 9.1 ± 1.0 | < 0.001 |
| Placental abruption | 15 (10.1%) | 13 (15.1%) | 2 (3.2%) | 0.018 |
| Premature rupture of membranes | 8 (5.4%) | 6 (7.0%) | 2 (3.2%) | 0.315 |
| Emergency cesarean section | 105 (70.9%) | 65 (75.6%) | 40 (65.5%) | 0.181 |
| NICU recovery | 140 (94.6%) | 84 (97.7%) | 56 (90.3%) | 0.050 |
| Hypoglycemia | 10 (6.7%) | 7 (8.1%) | 3 (4.8%) | 0.430 |
| Neonatal sepsis | 13 (8.8%) | 9 (10.5%) | 4 (6.4%) | 0.386 |
| Neonatal seizures | 5 (3.4%) | 3 (3.5%) | 2 (3.2%) | 0.921 |
| Acute respiratory distress syndrome | 88 (59.5%) | 61 (71.0%) | 27 (43.5%) | < 0.001 |
| Bronchopulmonary dysplasia | 1 (0.7%) | 1 (0.7%) | 0 (0%) | 0.511 |
| Pneumothorax | 19 (12.8%) | 10 (11.6%) | 9 (14.5%) | 0.604 |
| Non-invasive ventilation | 97 (65.5%) | 64 (74.4%) | 33 (53.2%) | 0.008 |
| Invasive ventilation | 29 (19.6%) | 22 (25.6%) | 7 (11.3%) | 0.031 |
| Steroid treatment | 12 (8.1%) | 13 (15.1%) | 10 (16.1%) | 0.869 |
| Caffeine treatment | 8 (5.4%) | 6 (7.0%) | 2 (3.2%) | 0.315 |
| Blood transfusion | 36 (24.3%) | 28 (32.5%) | 8 (13.0%) | 0.007 |
| Retinopathy of prematurity | 2 (1.3%) | 1 (1.2%) | 1 (1.6%) | 0.837 |
| Altered sleep-wake cycle | 7 (4.7%) | 6 (7.0%) | 1 (1.6%) | 0.128 |
| Gastrointestinal disorders | 20 (13.5%) | 9 (10.5%) | 11 (17.7%) | 0.208 |
| Pathological otoacoustic emissions | 3 (2.0%) | 3 (3.5%) | 0 (0%) | 0.138 |
| Normal cranial ultrasound | 93 (62.8%) | 57 (66.3%) | 36 (58.0%) | 0.304 |
| Transient flares | 36 (24.3%) | 19 (22.1%) | 11 (17.7%) | 0.512 |
| IVH 1 | 9 (6.1%) | 7 (8.1%) | 2 (3.2%) | 0.219 |
Data in bold are statistically significant.